STOCK TITAN

Ionis to present at upcoming investor conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Ionis Pharmaceuticals (Nasdaq: IONS) has announced its participation in two upcoming investor conferences. The company's management will engage in fireside chats at the 2024 Wells Fargo Healthcare Conference on September 4, 2024, and the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, 2024.

Investors and interested parties can access live webcasts of these presentations through the Investors & Media section of the Ionis website at https://ir.ionis.com/events-and-presentations/upcoming-events. Replays of the presentations will be available on the website within 48 hours and will be archived for a time, providing an opportunity for those unable to attend the live events to stay informed about the company's updates and strategies.

Ionis Pharmaceuticals (Nasdaq: IONS) ha annunciato la sua partecipazione a due prossime conferenze per investitori. La direzione dell'azienda parteciperà a discussioni informali al 2024 Wells Fargo Healthcare Conference il 4 settembre 2024, e al Morgan Stanley 22nd Annual Global Healthcare Conference il 5 settembre 2024.

Investitori e parti interessate possono accedere alle webcasting dal vivo di queste presentazioni attraverso la sezione Investitori & Media del sito Ionis all'indirizzo https://ir.ionis.com/events-and-presentations/upcoming-events. Le registrazioni delle presentazioni saranno disponibili sul sito entro 48 ore e saranno archiviate per un certo periodo, offrendo l'opportunità a chi non può partecipare agli eventi dal vivo di rimanere aggiornato sulle novità e strategie dell'azienda.

Ionis Pharmaceuticals (Nasdaq: IONS) ha anunciado su participación en dos próximas conferencias para inversores. La dirección de la empresa participará en charlas informales en la 2024 Wells Fargo Healthcare Conference el 4 de septiembre de 2024, y en la Morgan Stanley 22nd Annual Global Healthcare Conference el 5 de septiembre de 2024.

Los inversores y partes interesadas pueden acceder a transmisiones en vivo de estas presentaciones a través de la sección de Inversores y Medios del sitio Ionis en https://ir.ionis.com/events-and-presentations/upcoming-events. Las repeticiones de las presentaciones estarán disponibles en el sitio dentro de 48 horas y se archivarían por un tiempo, lo que brinda la oportunidad a aquellos que no puedan asistir a los eventos en vivo de mantenerse informados sobre las actualizaciones y estrategias de la empresa.

아이오니스 제약(Ionis Pharmaceuticals) (Nasdaq: IONS)은 두 개의 다가오는 투자자 회의에 참가할 것이라고 발표했습니다. 회사의 경영진은 2024 웰스 파고 헬스케어 컨퍼런스에서 2024년 9월 4일, 그리고 모건 스탠리 제22회 연례 글로벌 헬스케어 컨퍼런스에서 2024년 9월 5일에 대화에 참여할 예정입니다.

투자자 및 관심 있는 사람들이 아이오니스 웹사이트 https://ir.ionis.com/events-and-presentations/upcoming-events의 투자자 및 미디어 섹션을 통해 이러한 발표의 라이브 웹캐스트에 접근할 수 있습니다. 발표의 재생은 48시간 이내에 웹사이트에서 이용 가능하며 일정 기간 아카이브됩니다. 이는 라이브 이벤트에 참석할 수 없는 사람들에게 회사의 업데이트 및 전략에 대한 정보를 유지할 수 있는 기회를 제공합니다.

Ionis Pharmaceuticals (Nasdaq: IONS) a annoncé sa participation à deux prochaines conférences pour investisseurs. La direction de l'entreprise participera à des discussions informelles lors de la 2024 Wells Fargo Healthcare Conference le 4 septembre 2024, et de la Morgan Stanley 22nd Annual Global Healthcare Conference le 5 septembre 2024.

Les investisseurs et les parties intéressées peuvent accéder aux webinaires en direct de ces présentations via la section Investisseurs & Médias du site Ionis à l'adresse https://ir.ionis.com/events-and-presentations/upcoming-events. Les rediffusions des présentations seront disponibles sur le site dans les 48 heures et seront archivées pendant un certain temps, offrant ainsi l'opportunité à ceux qui ne peuvent pas assister aux événements en direct de rester informés des mises à jour et des stratégies de l'entreprise.

Ionis Pharmaceuticals (Nasdaq: IONS) hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen bekannt gegeben. Das Management des Unternehmens wird am 2024 Wells Fargo Healthcare Conference am 4. September 2024 und der Morgan Stanley 22nd Annual Global Healthcare Conference am 5. September 2024 an Diskussionsrunden teilnehmen.

Investoren und Interessierte können über den Bereich Investoren & Medien auf der Ionis-Website unter https://ir.ionis.com/events-and-presentations/upcoming-events auf Live-Webcasts dieser Präsentationen zugreifen. Wiederholungen der Präsentationen werden innerhalb von 48 Stunden auf der Website verfügbar sein und für eine gewisse Zeit archiviert werden, was denjenigen die Möglichkeit gibt, die an den Live-Events nicht teilnehmen konnten, über die Updates und Strategien des Unternehmens informiert zu bleiben.

Positive
  • None.
Negative
  • None.

CARLSBAD, Calif., Aug. 28, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:

  • 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024
  • Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, 2024

A live webcast of these presentations can be accessed on the Investors & Media section of the Ionis website at https://ir.ionis.com/events-and-presentations/upcoming-events. A replay will be available on the Ionis website within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients.

To learn more about Ionis, visit Ionis.com and follow us on X (Twitter) and LinkedIn.

Ionis Pharmaceuticals Investor Contact:
D. Wade Walke, Ph.D. – ir@ionis.com – 760-603-2331

Ionis Pharmaceuticals Media Contact:
Hayley Soffer – media@ionis.com – 760-603-4679

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-302232168.html

SOURCE Ionis Pharmaceuticals, Inc.

FAQ

When is Ionis Pharmaceuticals (IONS) participating in the Wells Fargo Healthcare Conference?

Ionis Pharmaceuticals (IONS) is participating in the 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024.

What investor conference is Ionis Pharmaceuticals (IONS) attending on September 5, 2024?

Ionis Pharmaceuticals (IONS) is attending the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, 2024.

How can investors access the live webcasts of Ionis Pharmaceuticals' (IONS) investor conference presentations?

Investors can access the live webcasts of Ionis Pharmaceuticals' (IONS) presentations through the Investors & Media section of the Ionis website at https://ir.ionis.com/events-and-presentations/upcoming-events.

How long will the replays of Ionis Pharmaceuticals' (IONS) investor conference presentations be available?

Replays of Ionis Pharmaceuticals' (IONS) investor conference presentations will be available on the company's website within 48 hours and will be archived for a time.

Ionis Pharmaceuticals, Inc.

NASDAQ:IONS

IONS Rankings

IONS Latest News

IONS Stock Data

5.19B
145.97M
0.78%
99.5%
6.26%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
CARLSBAD